Affluent Medical focuses on breakthrough therapies with a new approach of medical devices. We develop new generation of minimally invasive prostheses with the aim of mimicking anatomy and restoring native physiology for critical functions.
Our mission: save and improve patients’ lives with a range of disruptive prostheses
Physiological design
Minimally invasive
Improving patient care and surgeon usage
Disruptive Prostheses Addressing Unmet Needs
Medical Devices
Urology
Urinary incontinence
ARTUS
The device is in clinical development
Structural heart
Mitral valve repair
KALIOS
The device is in clinical development
Structural heart
Mitral valve replacement
EPYGON
The device is in clinical development
Technology
Abdominal aortic aneurysm
KARDIOZIS
The device is in clinical development
MINIMALLY INVASIVE PROSTHESES
News
IPO launch on Euronext Paris
AFFLUENT MEDICAL launches its IPO on the regulated Euronext Paris market • Capital increase of approximately €33.0 million, which may be increased...
Epygon publication
Affluent Medical published preclinical data in the renowned ANNALS OF THORACIC SURGERY confirming the potential of its Epygon mitral valve to...
Approval of the Registration Document
AFFLUENT MEDICAL announces the approval of its Registration Document by the French Financial Markets Authority (Autorité des marchés financiers –...
